Your supplement label is more than a marketing tool. It is a legal document that the U.S. Food and Drug Administration (FDA) reviews if a problem ever arises. A single missing word, wrong order, or unsupported claim can trigger a warning letter, force a relabeling project, or even lead to a recall.
This guide breaks down FDA supplement labeling requirements in plain language. You will learn every panel that must appear on the bottle, the disclaimers the FDA expects, the difference between safe and risky claims, and a checklist you can use before any label goes to print. By the end, you will know how to design a compliant label that protects your brand and builds trust with your customers.
Why FDA Supplement Labeling Requirements Matter
Dietary supplements are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994 and 21 CFR Part 101. Unlike drugs, supplements do not need pre-market approval. That freedom comes with a trade-off. The FDA places the full burden of label accuracy on the brand owner, not the contract manufacturer.
If a label is wrong, the FDA can issue a Form 483, a warning letter, or order a recall. State attorneys general and class action firms also scan labels for violations. The financial risk is real. A single relabeling project can cost more than the original print run, and a recall can wipe out a year of profit.
Who Is Responsible for Label Compliance
Every party in the supply chain shares some duty, but the brand on the front of the bottle is the legal “responsible party.” That is the company the FDA contacts first. A strong manufacturing partner reviews your artwork before printing, but the final sign-off belongs to you. This is why a careful pre-print review process is not a luxury. It is a basic part of running a supplement brand.
The 2025 FDA Update You Should Know
In December 2025, the FDA issued enforcement discretion guidance on the standard DSHEA disclaimer for certain digital and print formats. The core rule has not changed. The disclaimer is still required on the bottle. But brands have new flexibility on how it appears in companion materials. Always confirm the current rule with your regulatory consultant or manufacturer before relying on any update.
The 7 Required Elements on Every Supplement Label
The FDA requires seven specific items on every dietary supplement label. They must appear in the right place, in the right type size, and in the right order.
1. Statement of Identity
This is the product name and the words “dietary supplement” (or a more specific term like “herbal supplement”). It must appear on the principal display panel, which is the front of the package. The statement of identity tells the customer and the FDA exactly what the product is.
2. Net Quantity of Contents
This shows how much product is in the package. For capsules, it is the count (for example, “60 capsules”). For powders, it is weight (for example, “300 g (10.6 oz)”). The net quantity must appear in the bottom 30% of the principal display panel and must use both metric and U.S. customary units.
3. Supplement Facts Panel
The Supplement Facts panel is the heart of the label. It must include:
- Serving size and servings per container
- Each dietary ingredient with the amount per serving
- Percent Daily Value (%DV) for nutrients with established DVs
- A footnote explaining %DV when applicable
- Source ingredients in parentheses (for example, “Vitamin C (as ascorbic acid)”)
Format rules are strict. Type size, line spacing, and bolding all matter. The FDA publishes sample panels you can use as templates.
4. Ingredient List
Below the Supplement Facts panel, list any “other ingredients” that are not dietary ingredients. This includes capsule shells, fillers, flow agents, colors, and flavors. Ingredients must appear in descending order by weight.
5. Allergen Statement
The Food Allergen Labeling and Consumer Protection Act (FALCPA) requires a clear “Contains” statement for any of the nine major allergens: milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. Cross-contact warnings (“Manufactured in a facility that also processes…”) are voluntary but smart for transparency.
6. Manufacturer or Distributor Information
The label must list the name and full street address of the manufacturer, packer, or distributor. A phone number or website is recommended but not required. If you only list the city and state, the company must be findable in a current phone or business directory.
7. The DSHEA Disclaimer
If your label includes a structure/function claim, you must include this exact statement, set apart from other text:
“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
The disclaimer must appear on the same panel as the claim, in a type size at least as large as the claim itself.
Structure/Function Claims vs. Disease Claims
This is where most new brands run into trouble. The FDA draws a sharp line between two types of claims, and crossing it is the fastest way to get a warning letter.
What You Can Say: Structure/Function Claims
Structure/function claims describe how a nutrient supports the normal structure or function of the body. They are allowed without FDA approval as long as they are truthful and supported by evidence. Examples:
- “Supports a healthy immune system”
- “Promotes joint comfort”
- “Helps maintain healthy cholesterol levels already within normal range”
These claims trigger the DSHEA disclaimer requirement. You must also notify the FDA of any structure/function claim within 30 days of first marketing the product.
What You Cannot Say: Disease Claims
Disease claims state or imply that a product treats, cures, prevents, or mitigates a disease. These are reserved for drugs. Examples that cross the line:
- “Lowers cholesterol” (implies treatment of hypercholesterolemia)
- “Prevents arthritis”
- “Cures the common cold”
- “Reduces blood pressure”
Even subtle wording matters. “Supports healthy blood pressure already within normal range” is allowed. “Lowers blood pressure” is not. Review every word with this lens before printing.
Qualified Health Claims
A small number of claims have FDA-authorized qualified language (for example, the calcium and osteoporosis claim). These require specific wording. Do not paraphrase. Use the exact language the FDA has authorized.
Common Labeling Mistakes That Trigger FDA Action
Even careful brands slip up. These are the issues we see most often during pre-print reviews.
Wrong Serving Size or %DV
The %DV is calculated from FDA reference values, not from your formula. Using the wrong reference value (or rounding incorrectly) is one of the most common Form 483 findings.
Missing or Tiny Disclaimers
The DSHEA disclaimer must be conspicuous. Hiding it on a side panel or shrinking the type to fit a design is a clear violation.
Misleading Imagery
A picture of a heart next to a structure/function claim about cholesterol can be read as a disease claim. Imagery counts as labeling.
Unapproved Ingredients
New Dietary Ingredients (NDIs) introduced after October 15, 1994 require a separate FDA notification at least 75 days before marketing. Skipping this step is a major violation.
Inconsistent Net Quantity
The label says “60 capsules” but the bottle holds 58. Fill weight and count tolerances are tight, and the FDA does check.
For deeper guidance on certifications that signal trust to retailers and consumers, review our guide on GMP certification for supplement manufacturing and our contract manufacturing services.
Your Pre-Print Label Compliance Checklist
Before any label goes to the printer, walk through this list:
- Statement of identity includes “dietary supplement”
- Net quantity appears in both metric and U.S. units
- Supplement Facts panel uses correct format and type size
- All ingredients list source forms in parentheses
- Other ingredients are in descending order by weight
- Allergen “Contains” statement is present
- Manufacturer or distributor name and address are complete
- DSHEA disclaimer appears with any structure/function claim
- No language crosses into disease claim territory
- Imagery does not imply disease treatment
- Lot number and expiration date placement is planned
- Barcode meets retailer requirements (if applicable)
- FDA notification filed for any structure/function claim
- NDI notifications complete for any post-1994 ingredients
A second set of eyes always helps. Many brands route the final artwork through both their manufacturer and an outside regulatory consultant. The cost is small compared to a recall.
How a Manufacturing Partner Reduces Your Label Risk
Working with a GMP-certified manufacturer that handles label design in-house gives you a clear advantage. Your artwork moves through the same compliance review used for production records. Catches happen earlier, and the team knows the specific rules for each format you produce.
At BioThrive Sciences, our in-house design team reviews every private label artwork against the latest FDA rules before it goes to print. We have helped hundreds of brands avoid costly relabeling and have flagged claim language that would have drawn FDA attention. To learn how we support new brands from formula to finished label, visit our private label manufacturing page or explore our custom formulations services.
Common Questions About FDA Supplement Labeling Requirements (FAQ)
Q: Does the FDA approve supplement labels before they are printed? A: No. The FDA does not pre-approve dietary supplement labels. The brand owner is fully responsible for compliance. The FDA reviews labels reactively, often after a complaint or during a routine inspection.
Q: What is the difference between a structure/function claim and a disease claim? A: A structure/function claim describes how a nutrient supports normal body function (allowed with the DSHEA disclaimer). A disease claim states or implies the product treats, cures, prevents, or mitigates a disease (not allowed for supplements).
Q: How big must the DSHEA disclaimer be on a supplement label? A: The disclaimer must appear on the same panel as the structure/function claim and use a type size no smaller than the claim itself. It must also be set apart from other text so it is conspicuous.
Q: Do I need to notify the FDA about every claim on my label? A: You must notify the FDA within 30 days of first marketing any product that bears a structure/function claim. The notification is filed by the responsible party (usually the brand owner).
Q: What happens if my supplement label is not compliant? A: The FDA can issue a warning letter, require relabeling, or order a recall. State regulators and class action attorneys can also bring enforcement actions. Most issues are caught during pre-print review when a knowledgeable manufacturer or consultant flags the problem early.
Conclusion
FDA supplement labeling requirements are detailed, but they are not mysterious. The seven required elements, the line between structure/function and disease claims, and the DSHEA disclaimer cover most of what you need to know. Build a pre-print checklist, work with a manufacturer that reviews artwork against current FDA rules, and never skip the second set of eyes.
Three takeaways to remember: the brand owner carries final responsibility, every word and image counts, and the cost of compliance is always lower than the cost of a recall. If you are designing your first label or reviewing an existing one, our team can help. Reach out through our contact page to schedule a label compliance review and start your next product on solid ground.